Development of New Tests for Applications in Prevention and Personalized Healthcare – Extended HLA testing portfolio includes products to assess tolerance for Lumiracoxib and for the early detection of inflammatory diseases Germantown, MD and Hilden, Germany — QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has entered into an agreement with the […]
MUKILTEO, Wash. — — CombiMatrix Corporation (Nasdaq:CBMX) announced today that its laboratory services subsidiary, CombiMatrix Diagnostics, has received the final licensure documentation and approvals from Medicare in order to begin billing for its suite of array-based diagnostics tests. “We have publicly disclosed that our Company continues to make significant progress on the reimbursement front,” stated […]
Jena — Analytik Jena AG and SIRS-Lab GmbH, also based in Jena, will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the associated reagent system worth […]
Molecular profiling test utilizes common clinical specimen type to help identify cancers REDWOOD CITY, Calif. — Pathwork Diagnostics Inc., a molecular diagnostics company focused on oncology, today announced the U.S. Food and Drug Administration (FDA) cleared the Pathwork® Tissue of Origin Test for formalin-fixed, paraffin-embedded (FFPE) tissues. The FDA clearance allows the Tissue of Origin […]
PARIS — — Regulatory News — “This pilot study clearly demonstrates the ability of ExonHit’s technology to identify novel target candidates for breast cancer treatment approaches.” ExonHit applied its genome-wide SpliceArray™ technology to develop a unique database in breast cancer Genmab retains exclusive rights on 10 novel splice events to fuel its antibody discovery activity […]
Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, today announces a major distribution agreement with Fisher HealthCare for ABI’s PIFA® Heparin/PF4 Rapid Assay (PIFA HPF4) and related products. Fisher HealthCare is one of the USA’s leading healthcare product channels. The addition of Fisher HealthCare’s resources will expose […]
MUKILTEO, Wash. — — CombiMatrix Corporation (Nasdaq:CBMX) announced today that its Board of Directors has appointed Mark McGowan to the role of Interim President and Chief Executive Officer, effective July 1, 2010 upon the transition from current President and CEO, Dr. Amit Kumar. Dr. Amit Kumar stated, “As we had previously announced, I plan to […]
Tecan to supply high-throughput instruments to provide blood banks with flexible pooling and archiving solution – Supply of first instruments expected in 2010 Männedorf, Switzerland — The Tecan Group (SIX Swiss Exchange: TECN) today announced a global OEM agreement with the diagnostics business of Novartis for the supply of a new high-throughput instrument designed to […]
Colonized Patients are Most at Risk for Serious Complications of S. aureus Infection SUNNYVALE, Calif. — — Cepheid (Nasdaq:CPHD – News) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of […]
Agreements include surgical blades, critical care and extended dwell catheter product platforms FRANKLIN LAKES, N.J. — — BD (Becton, Dickinson and Company) (NYSE:BDX – News), a leading global medical technology company, announced today that it has signed agreements to sell certain assets of its BD Medical segment, including the Ophthalmic Systems unit as well as […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
